Vimarsana
Biggest News Aggregation in the World

Page 31 - Tender Offer Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tender Offer Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tender Offer Statement Today - Breaking & Trending Today

Dalliance Services Company Announces Availability of Bidder Financial Statements in Connection with QIWI PLC Tender Offer - Vimarsana News

Dalliance Services Company Announces Availability of Bidder Financial Statements in Connection with QIWI PLC Tender Offer

Dalliance Services Company, a corporation incorporated under the laws of the Marshall Islands (the "Offeror") and wholly owned by Sergey Solonin, the controlling shareholder and chairman of the board

Dalliance Services Company Announces Extension of QIWI PLC Tender Offer - Vimarsana News

Dalliance Services Company Announces Extension of QIWI PLC Tender Offer

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Dalliance Services Company Announces Extension of QIWI PLC Tender Offer - Vimarsana News

Dalliance Services Company Announces Extension of QIWI PLC Tender Offer

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Ipsen Extends Expiration Date of Tender Offer for Epizyme, Inc. to 11 August 2022 - Vimarsana News

Ipsen Extends Expiration Date of Tender Offer for Epizyme, Inc. to 11 August 2022

Extension allows for satisfaction of the HSR Condition as outlined in the Merger Agreement Epizyme stockholders are encouraged to tender their shares to the offer today Regulatory News: Ipsen

Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

Theravance Biopharma, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update

Highest quarter of YUPELRI® (revefenacin) net sales and profitability to date1: $17.2M Q2 2022 sales up 17% from Q2 2021 (implied 35% share) Ampreloxetine...